Jiazheng Sun

876 total citations
20 papers, 606 citations indexed

About

Jiazheng Sun is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiazheng Sun has authored 20 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Jiazheng Sun's work include Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (3 papers) and Breast Cancer Treatment Studies (3 papers). Jiazheng Sun is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (3 papers) and Breast Cancer Treatment Studies (3 papers). Jiazheng Sun collaborates with scholars based in China, Sweden and Singapore. Jiazheng Sun's co-authors include Guosheng Ren, Yunhai Li, Hongzhong Li, Dejuan Yang, Jing Huang, Beilei Zeng, Tingxiu Xiang, Xuedong Yin, Ping He and Keli Zhong and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiazheng Sun

19 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiazheng Sun China 13 315 191 176 89 77 20 606
Xiaoqing Wang China 14 319 1.0× 204 1.1× 124 0.7× 35 0.4× 44 0.6× 39 575
Philip M. Tedeschi United States 11 523 1.7× 309 1.6× 85 0.5× 62 0.7× 52 0.7× 12 760
Jinting Zhou China 13 311 1.0× 144 0.8× 97 0.6× 24 0.3× 71 0.9× 26 543
Jinsheng Wu China 13 321 1.0× 144 0.8× 54 0.3× 44 0.5× 51 0.7× 31 478
Mingdong Liu China 14 272 0.9× 181 0.9× 73 0.4× 30 0.3× 114 1.5× 30 629
Ana María Eiján Argentina 18 330 1.0× 173 0.9× 128 0.7× 62 0.7× 15 0.2× 54 717
Jintao Zhao China 12 220 0.7× 90 0.5× 82 0.5× 56 0.6× 26 0.3× 40 417
Erica Pranzini Italy 14 373 1.2× 262 1.4× 107 0.6× 33 0.4× 22 0.3× 31 577
Sonia Dolfi United States 14 431 1.4× 223 1.2× 289 1.6× 43 0.5× 19 0.2× 33 756

Countries citing papers authored by Jiazheng Sun

Since Specialization
Citations

This map shows the geographic impact of Jiazheng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiazheng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiazheng Sun more than expected).

Fields of papers citing papers by Jiazheng Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiazheng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiazheng Sun. The network helps show where Jiazheng Sun may publish in the future.

Co-authorship network of co-authors of Jiazheng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jiazheng Sun. A scholar is included among the top collaborators of Jiazheng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiazheng Sun. Jiazheng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoyu, Jiakui Li, Yushen Wu, et al.. (2025). AEBP1 drives fibroblast-mediated T cell dysfunction in tumors. Nature Communications. 16(1). 8171–8171.
2.
Sun, Jiazheng, Peng Yang, Xianbin Cao, et al.. (2024). Pilot-Aided Joint Time Synchronization and Channel Estimation for OTFS. IEEE Wireless Communications Letters. 14(1). 143–147. 2 indexed citations
3.
Chen, Yuru, Jiazheng Sun, Jiazhou Liu, et al.. (2023). Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis. Journal for ImmunoTherapy of Cancer. 11(12). e007487–e007487. 16 indexed citations
4.
Chen, Yuru, Jiazheng Sun, Jiazhou Liu, et al.. (2022). Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. Journal of Translational Medicine. 20(1). 615–615. 31 indexed citations
5.
Wu, Yushen, Ziying Yi, Jie Li, et al.. (2022). FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts. Theranostics. 12(10). 4564–4580. 64 indexed citations
6.
Liu, Jiazhou, Xiaoyu Wang, Jiazheng Sun, et al.. (2022). The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy. Frontiers in Cell and Developmental Biology. 9. 798221–798221. 5 indexed citations
8.
Wang, Jing, Xiaoyu Wang, Zhenyu Zhong, et al.. (2021). Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study. Frontiers in Oncology. 11. 642571–642571. 4 indexed citations
9.
Liu, Jiazhou, Yuxian Wei, Yushen Wu, et al.. (2021). ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer. Frontiers in Immunology. 12. 657950–657950. 13 indexed citations
10.
Wang, Kang, Jiazheng Sun, Yongfu Xiong, et al.. (2020). Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study. npj Breast Cancer. 6(1). 36–36. 38 indexed citations
11.
Wu, Yushen, Beilei Zeng, Jiazheng Sun, et al.. (2020). CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis. Biochemical and Biophysical Research Communications. 526(2). 306–313. 40 indexed citations
12.
Li, Yunhai, Dejuan Yang, Ping Chen, et al.. (2019). Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis. Aging. 11(16). 6286–6311. 24 indexed citations
13.
Li, Yunhai, Jing Huang, Beilei Zeng, et al.. (2018). PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation. Cancer Letters. 430. 109–122. 83 indexed citations
14.
Li, Yunhai, Jing Huang, Dejuan Yang, et al.. (2018). Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer. Oncology Letters. 15(6). 9216–9230. 52 indexed citations
15.
Yang, Dejuan, Yunhai Li, Lei Xing, et al.. (2018). Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression. Cell Communication and Signaling. 16(1). 32–32. 62 indexed citations
16.
Sun, Jiazheng, Jing Zhang, Yue Shao, et al.. (2018). Protective effects of ginsenoside Rg1 on splenocytes and thymocytes in an aging rat model induced by d-galactose. International Immunopharmacology. 58. 94–102. 49 indexed citations
17.
Tang, Lijun, Ping He, Xiaomei Yan, et al.. (2017). A mitochondria-targetable fluorescent probe for ratiometric detection of SO2 derivatives and its application in live cell imaging. Sensors and Actuators B Chemical. 247. 421–427. 92 indexed citations
18.
Li, Yunhai, Jiazheng Sun, Jing Huang, et al.. (2016). Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease. Scientific Reports. 6(1). 33550–33550. 3 indexed citations
19.
Li, Yunhai, Jing Huang, Jiazheng Sun, et al.. (2016). The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers. Oncotarget. 8(3). 4501–4519. 23 indexed citations
20.
Zhang, Xiaoqiao, et al.. (2006). Simplified Techniques in Rat Heterotopic Small Bowel Transplantation. Transplantation Proceedings. 38(6). 1840–1841. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026